Madrigal Pharmaceuticals
MDGL
#2088
Rank
ยฃ6.73 B
Marketcap
ยฃ289.79
Share price
-4.45%
Change (1 day)
-30.75%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2026 (TTM): -ยฃ92.56 Million

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ1.42 Billion. In 2025 the company made an earning of -ยฃ0.21 Billion, an increase over its 2024 earnings that were of -ยฃ0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ92.56 Million-54.48%
2025 -ยฃ0.21 Billion-41.05%
2024 -ยฃ0.35 Billion25.02%
2023 -ยฃ0.28 Billion23.86%
2022 -ยฃ0.23 Billion20.24%
2021 -ยฃ0.19 Billion17.25%
2020 -ยฃ0.16 Billion117.61%
2019 -ยฃ72.6 Million189.45%
2018 -ยฃ25.09 Million3.85%
2017 -ยฃ24.16 Million25.71%
2016 -ยฃ19.22 Million-50.81%
2015 -ยฃ39.06 Million-39.14%
2014 -ยฃ64.18 Million-4.12%
2013 -ยฃ66.94 Million
2011 -ยฃ34.73 Million23.13%
2010 -ยฃ28.21 Million-145.81%
2009 ยฃ61.56 M-185.95%
2008 -ยฃ71.64 Million41.52%
2007 -ยฃ50.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-ยฃ0.13 Billion 29.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.88 Million-85.28%๐Ÿ‡บ๐Ÿ‡ธ USA